~ Buy the CHERRY Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) CHERRY

Branded drugs containing CHERRY excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
NextWave Pharmaceuticals Inc	QUILLICHEW ER	methylphenidate hydrochloride	24478-074	CHERRY
NextWave Pharmaceuticals Inc	QUILLICHEW ER	methylphenidate hydrochloride	24478-120	CHERRY
Janssen Pharmaceuticals Inc	SPORANOX	itraconazole	50458-295	CHERRY
Physicians Total Care Inc	NULYTELY	peg-3350, sodium chloride, sodium bicarbonate and potassium chloride	54868-4233	CHERRY
TAKEDA PHARMACEUTICALS AMERICA INC	EOHILIA	budesonide	64764-105	CHERRY
Genus Lifesciences Inc	HYCODAN	hydrocodone bitartrate and homatropine methylbromide	64950-342	CHERRY

Generic drugs containing CHERRY excipient

Company	Ingredient	NDC	Excipient
Hikma Pharmaceuticals USA	methadone hydrochloride	0054-0392	CHERRY
WALGREEN CO	ibuprofen	0363-8901	CHERRY
Actavis Pharma Inc	hydrocodone bitartrate and homatropine methylbromide	0472-1030	CHERRY
7-Eleven	ibuprofen	10202-150	CHERRY
KVK-Tech Inc	hydrocodone bitartrate and homatropine methylbromide oral solution	10702-150	CHERRY
Apotheca Inc	prednisolone	12634-686	CHERRY

CHERRY Market Analysis and Financial Projection Experimental

Pharmaceutical Excipients Market Dynamics and Financial Trajectory

Introduction to Pharmaceutical Excipients

Pharmaceutical excipients are inert substances used in the formulation of drugs to enhance the stability, bioavailability, and overall performance of the active pharmaceutical ingredients (APIs). These components are crucial in the development of effective and patient-friendly drug formulations.

Global Market Overview

The global pharmaceutical excipients market is experiencing significant growth, driven by various factors such as technological advancements, increasing demand for generic drugs, and the rise in chronic diseases.

• Market Size and Growth Rate: The global pharmaceutical excipients market was valued at approximately USD 8.37 billion in 2023 and is projected to reach USD 14.72 billion by 2033, growing at a CAGR of 5.81% from 2024 to 2033[1][2][3].

Regional Market Analysis

North America

• North America dominated the market with a share of around 39% in 2023.
• The North America pharmaceutical excipients market is expected to reach USD 5.77 billion by 2033, growing at a CAGR of 6.02% from 2024 to 2033[2].

Europe

• Europe is a significant market due to its strong pharmaceutical industry and favorable regulatory environment.
• The Europe pharmaceutical excipients market is anticipated to reach around USD 4.44 billion by 2033, expanding at a CAGR of 5.34% from 2024 to 2033[2].

Asia Pacific

• The Asia Pacific region is the fastest-growing market, driven by increasing demand for generic drugs and advancements in healthcare.
• The Asia Pacific pharmaceutical excipients market is expected to grow at a CAGR of 6.56% from 2024 to 2033 and reach a valuation of USD 3.55 billion by 2033[2].

Excipient Types and Functionalities

Lactose-Based Excipients

• Lactose-based excipients captured the maximum market share of around 42% in 2023 due to their widespread use in oral formulations[2].

Binders & Fillers

• Binders and fillers contributed the largest market share by functionality, accounting for around 50% of the market in 2023[2].

Drivers of Market Growth

Technological Advancements

• Innovations such as nanotechnology, lipid-based drug delivery, and 3D printing are revolutionizing drug development, creating a demand for advanced excipients[1].

Increasing Demand for Generic Drugs

• The escalating demand for generic drugs, coupled with an increase in chronic disease cases, necessitates the development of more effective and patient-friendly drug formulations[3].

Personalized Medicine

• The growing emphasis on personalized medicine and precision therapeutics will drive demand for tailored excipient solutions supporting individualized drug formulations[5].

Challenges and Restraints

Regulatory Challenges

• The stringent regulatory environment surrounding excipient approval and usage is a significant hurdle. Compliance with these regulations demands significant investment in research and testing[5].

Adverse Reactions and Contamination

• Adverse reactions of excipients and contamination in formulations can hinder market growth[3].

Key Players and Strategic Initiatives

• Leading companies such as ADM, BASF SE, Roquette Frères, Ashland Global, and Croda International Plc are driving innovation and sustainability in excipient development through strategic alliances, research collaborations, and acquisitions[5].

Future Outlook

The future of pharmaceutical excipients is filled with opportunities and potential breakthroughs. Here are some key trends and expectations:

Innovative Excipient Formulations

• The development of multifunctional and novel excipients will continue to enhance drug formulation efficiency and functionality[3].

Sustainability and Environmental Responsibility

• There will be an increased focus on sustainable practices and environmental responsibility in the production of pharmaceutical excipients[4].

Geographical Expansion

• Emerging markets, particularly in the Asia Pacific region, will play a significant role in the growth of the pharmaceutical excipients market[2].

Key Takeaways

• The global pharmaceutical excipients market is projected to grow significantly, driven by technological advancements and increasing demand for generic drugs.
• North America and Europe are key markets, but the Asia Pacific region is expected to be the fastest-growing.
• Lactose-based excipients and binders & fillers are dominant segments.
• Regulatory challenges and adverse reactions are significant restraints.
• Key players are investing heavily in innovation and sustainability.

FAQs

Q: What is the projected global market size for pharmaceutical excipients by 2033? A: The global pharmaceutical excipients market is expected to reach around USD 14.72 billion by 2033[1].

Q: Which region dominates the pharmaceutical excipients market? A: North America currently dominates the market with a share of around 39% in 2023[2].

Q: What are the primary drivers of growth in the pharmaceutical excipients market? A: Technological advancements, increasing demand for generic drugs, and the rise in chronic diseases are primary drivers[1][3].

Q: Which type of excipient holds the largest market share? A: Lactose-based excipients captured the maximum market share of around 42% in 2023[2].

Q: What are the major challenges facing the pharmaceutical excipients market? A: Regulatory challenges, adverse reactions of excipients, and contamination in formulations are significant challenges[3][5].

Cited Sources

1. Biospace: "Pharmaceutical Excipients Market Size USD 14.72 Billion by 2033 and CAGR 5.81 Percent"
2. Biospace: "Pharmaceutical Excipients Market Size to Surge to US$ 14.72 Billion by 2033, Unlocking New Growth Horizons"
3. Mordor Intelligence: "Pharmaceutical Excipients Market Size & Share Analysis"
4. The Business Research Company: "Global Cherries Market Report 2024" (Note: This source was not directly relevant but included for completeness)
5. BCC Research: "Understanding the Future of Pharmaceutical Excipients"